Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome

Authors Information
Article Notes and Dates
To Cite : Noripour S, Molaei A, Bandari R, Emadi A, Farokhi Far S M, et al. Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome, J Compr Ped. 2017 ;8(1):e37462. doi: 10.5812/compreped.37462.
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Naseh A, Yekta BG. INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate. Turk J Pediatr. 2014; 56(3): 232-7[PubMed]
  • 2. Nayeri FS, Esmaeilnia Shirvani T, Aminnezhad M, Amini E, Dalili H, Moghimpour Bijani F. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge. Acta Med Iran. 2014; 52(8): 596-600[PubMed]
  • 3. Sadeghnia A, Tanhaei M, Mohammadizadeh M, Nemati M. A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams. Adv Biomed Res. 2014; 3: 160[DOI][PubMed]
  • 4. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol. 2005; 25(11): 703-8[DOI][PubMed]
  • 5. Rodriguez RJ. Management of respiratory distress syndrome: an update. Respir Care. 2003; 48(3): 279-86[PubMed]
  • 6. Rodriguez R, Martin R, Fanaroff AA. Neonatal- Perinatal Medicine. 2006;
  • 7. Rocha G, Flor-de-Lima F, Proenca E, Carvalho C, Quintas C, Martins T, et al. Failure of early nasal continuous positive airway pressure in preterm infants of 26 to 30 weeks gestation. J Perinatol. 2013; 33(4): 297-301[DOI][PubMed]
  • 8. Ramanathan R. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS. J Perinatol. 2006; 26-6
  • 9. Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr. 2009; 98(9): 1412-5[DOI][PubMed]
  • 10. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics. 2004; 113(6)-3[PubMed]
  • 11. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999; 103(2)[PubMed]
  • 12. Krajewski P, Chudzik A, Strzalko-Gloskowska B, Gorska M, Kmiecik M, Wieckowska K, et al. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences. J Matern Fetal Neonatal Med. 2015; 28(10): 1161-4[DOI][PubMed]
  • 13. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol. 2007; 27(7): 422-7[DOI][PubMed]
  • 14. Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli FF. The INSURE method in preterm infants of less than 30 weeks' gestation. J Matern Fetal Neonatal Med. 2010; 23(9): 1024-9[DOI][PubMed]
  • 15. Moretti C, Papoff P, Giannini L, Gizzi C. Surfactant and non invasive ventilation. Pediatr Med Chir. 2005; 27(5): 26-9[PubMed]
  • 16. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001; (2)[DOI][PubMed]
  • 17. Duncan HP, Zurick NJ, Wolf AR. Should we reconsider awake neonatal intubation? A review of the evidence and treatment strategies. Paediatr Anaesth. 2001; 11(2): 135-45[PubMed]
  • 18. VanLooy JW, Schumacher RE, Bhatt-Mehta V. Efficacy of a premedication algorithm for nonemergent intubation in a neonatal intensive care unit. Ann Pharmacother. 2008; 42(7): 947-55[DOI][PubMed]
  • 19. Anand KJ. Pharmacological approaches to the management of pain in the neonatal intensive care unit. J Perinatol. 2007; 27 Suppl 1[DOI][PubMed]
  • 20. Carbajal R, Gall O, Annequin D. Pain management in neonates. Expert Rev Neurother. 2004; 4(3): 491-505[DOI][PubMed]
  • 21. Hume-Smith H, McCormack J, Montgomery C, Brant R, Malherbe S, Mehta D, et al. The effect of age on the dose of remifentanil for tracheal intubation in infants and children. Paediatr Anaesth. 2010; 20(1): 19-27[DOI][PubMed]
  • 22. Crawford MW, Hayes J, Tan JM. Dose-response of remifentanil for tracheal intubation in infants. Anesth Analg. 2005; 100(6): 1599-604[DOI][PubMed]
  • 23. Li T, Jiang H, Liu DY, Li XH. [Risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome]. Zhongguo Dang Dai Er Ke Za Zhi. 2014; 16(6): 610-3[PubMed]
  • 24. Polin RA, Carlo WA, Committee on F, American Academy of P. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014; 133(1): 156-63[DOI][PubMed]
  • 25. Najafian B, Fakhraie SH, Afjeh SA, Kazemian M, Shohrati M, Saburi A. Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome. Iran Red Crescent Med J. 2014; 16(4)[DOI][PubMed]
  • 26. Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Perinatol. 2008; 25(10): 647-52[DOI][PubMed]
  • 27. Kanewischer EJ, Harris SM. Deciding Not to Un-Do the "I Do:" Therapy Experiences of Women Who Consider Divorce But Decide to Remain Married. J Marital Fam Ther. 2015; 41(3): 367-80[DOI][PubMed]
  • 28. Mazmanyan PA. [CPAP as a method of primary respiratory support in premature infants with acute respiratory distress syndrome]. Anesteziol Reanimatol. 2013; (1): 31-4[PubMed]
  • 29. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007; (4)[DOI][PubMed]
  • 30. Escobedo MB, Gunkel JH, Kennedy KA, Shattuck KE, Sanchez PJ, Seidner S, et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr. 2004; 144(6): 804-8[DOI][PubMed]
  • 31. Iyer NP, Mhanna MJ. The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants. World J Pediatr. 2014; 10(3): 204-10[DOI][PubMed]
  • 32. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959; 97(5, Part 1): 517-23[PubMed]
  • 33. Enhorning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics. 1972; 50(1): 58-66[PubMed]
  • 34. Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T. Artificial Surfactant Therapy in Hyaline-Membrane Disease. Lancet. 1980; 315(8159): 55-9[DOI]
  • 35. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child. 1993; 69(3 Spec No): 276-80[PubMed]
  • 36. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American Study G. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004; 21(3): 109-19[DOI][PubMed]
  • 37. Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr. 2005; 94(6): 779-84[DOI][PubMed]
  • 38. Cogo PE, Facco M, Simonato M, Verlato G, Rondina C, Baritussio A, et al. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics. 2009; 124(5)-7[DOI][PubMed]
  • 39. De Jaegere AP, Deurloo EE, van Rijn RR, Offringa M, van Kaam AH. Chest X-ray characteristics during oxygenation guided open lung ventilation in preterm infants with respiratory distress syndrome. 2012;
  • 40. Mostafa M, Gharehbaghi MM. Risk Factors Contributing to the Failure of Surfactant Administration with INSURE Method. J Pioneer Med Sci. 2013; 4(2): 55-9
  • 41. Choi YY, Park JY, Cho CY, Ma JS, Hwang TJ. Changes of neonatal mortality rate between 'pre' and 'post' surfactant period. J Korean Med Sci. 1999; 14(1): 45-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Journal of Comprehensive Pediatrics accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check